These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11249700)

  • 1. Role of antiplatelet agents in stroke.
    Mousa SA
    Curr Opin Investig Drugs; 2000 Dec; 1(4):464-7. PubMed ID: 11249700
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotics and thrombolytics in stroke.
    Mousa SA; Iqbal O; Fareed J
    Curr Opin Investig Drugs; 2002 Jun; 3(6):878-85. PubMed ID: 12137407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of acute stroke].
    Sztajzel R; Reichhart M; Michel P; Bogousslavsky J
    Rev Med Suisse; 2005 May; 1(18):1192-4, 1197-200. PubMed ID: 15977707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GP IIb/IIIa blockade during peripheral artery interventions.
    Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH
    Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Fernandez JS; Sadaniantz A
    Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
    [No Abstract]   [Full Text] [Related]  

  • 6. Reperfusion synergism: will it be both sustained and safe?
    Armstrong PW
    Eur Heart J; 2000 Dec; 21(23):1913-6. PubMed ID: 11071795
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiplatelet agents--problem for cardiac surgeon].
    Bochenek A; Wilczyński M
    Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
    [No Abstract]   [Full Text] [Related]  

  • 8. Unstable angina.
    Natarajan M
    Clin Evid; 2002 Jun; (7):214-26. PubMed ID: 12230645
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental treatments for acute ischaemic stroke.
    Sacco RL; Chong JY; Prabhakaran S; Elkind MS
    Lancet; 2007 Jan; 369(9558):331-41. PubMed ID: 17258673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in pharmacotherapy of thrombosis.
    Labuzek K; Krysiak R; Okopien B; Herman ZS
    Pol J Pharmacol; 2003; 55(4):523-33. PubMed ID: 14581710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
    Konstantopoulos K; Mousa SA
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
    Chew DP; Moliterno DJ; Herrmann HC
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
    [No Abstract]   [Full Text] [Related]  

  • 13. [Risk stratification in the acute coronary syndrome. Diabetes--a diagnostic dilemma].
    Giannitsis E; Katus HA
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S211-4. PubMed ID: 17109251
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standard pharmacological therapy associated with percutaneous coronary interventions in patients with stable angina].
    Karcz M; Ruzyłło W
    Kardiol Pol; 2004 Nov; 61(11):480-2. PubMed ID: 15883598
    [No Abstract]   [Full Text] [Related]  

  • 16. Unstable angina.
    Natarajan M
    Clin Evid; 2002 Dec; (8):225-35. PubMed ID: 12603879
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 18. The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines.
    Hostetter JC; Bhatt DL
    Minerva Cardioangiol; 2003 Oct; 51(5):531-46. PubMed ID: 14551522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPIIb/IIIa inhibitor-induced dethrombosis.
    Furman MI; Frelinger AL; Michelson AD
    J Thromb Thrombolysis; 2004 Aug; 18(1):11-7. PubMed ID: 15744548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events.
    Zhang LJ; Chen YD; Song XT; Zhao FH; Lü SZ
    Chin Med J (Engl); 2009 Mar; 122(5):502-8. PubMed ID: 19323898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.